2021
Effects of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes in cancer survivors: a systematic review
Addison S, Shirima D, Aboagye-Mensah EB, Dunovan SG, Pascal EY, Lustberg MB, Arthur EK, Nolan TS. Effects of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes in cancer survivors: a systematic review. Journal Of Cancer Survivorship 2021, 16: 1023-1046. PMID: 34357555, PMCID: PMC8342979, DOI: 10.1007/s11764-021-01094-8.Peer-Reviewed Original ResearchConceptsHealth-related outcomesCognitive behavioral therapyCancer survivorsUsual careHL interventionsBehavioral therapyTandem interventionsBreast cancer survivorsHealthy lifestyle interventionUse of CBTCancer-related effectsLifestyle interventionAdvanced cancerLifestyle behaviorsEmbase databasesInclusion criteriaEfficacious interventionsSystematic reviewComprehensive searchCancer treatmentSurvivorsAdverse effectsInterventionOutcomesPaucity of knowledge
2016
Effects of exercise interventions during different treatments in breast cancer.
Fairman C, Focht B, Lucas A, Lustberg M. Effects of exercise interventions during different treatments in breast cancer. The Journal Of Community And Supportive Oncology 2016, 14: 200-9. PMID: 27258052, PMCID: PMC5522734, DOI: 10.12788/jcso.0225.Peer-Reviewed Original ResearchExercise interventionD effect sizesTreatment-related adverse effectsFemale breast cancer survivorsPsychosocial outcomesEfficacy of exerciseBreast cancer survivorsBreast cancer patientsBreast cancer treatmentActive cancer therapyPost-treatment interventionsType of treatmentCohen's d effect sizesCancer survivorsResistance exerciseAerobic exerciseCancer patientsInclusion criteriaMuscular strengthCardiovascular functioningLiterature searchCancer treatmentAdverse effectsModerate improvementCancer therapy
2013
Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review
Poi M, Berger M, Lustberg M, Layman R, Shapiro C, Ramaswamy B, Mrozek E, Olson E, Wesolowski R. Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review. Supportive Care In Cancer 2013, 21: 2679-2686. PMID: 23686402, PMCID: PMC3769512, DOI: 10.1007/s00520-013-1842-3.Peer-Reviewed Original ResearchConceptsBreast cancer patientsSkin toxicityCancer patientsCase seriesGranulocyte colony-stimulating factor supportToxicity eventsColony-stimulating factor supportDose-dense doxorubicinOperable stage IResultsThirty-four patientsSevere skin toxicityEvidence-based preventionElectronic medical recordsInstitutional review boardDermatologic toxicitiesDocetaxel 75Docetaxel monotherapyWeekly paclitaxelCyclophosphamide regimenClinical courseFactor supportMedical recordsTreatment strategiesGrade 3Inclusion criteria